A new study reveals several drug contenders already in use for other purposes that have been shown to block or reduce SARS-CoV2 infection in cells. The study uses artificial intelligence-powered ...

Folding of SARS-CoV2 genome reveals drug targets -- and preparation for 'SARS-CoV3'. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2020 / 11 / 201121104304.htm.

For the first time, an international research alliance has observed the RNA folding structures of the SARS-CoV2 genome with which the virus controls the infection process. Since these structures ...

SARS-CoV-2 is highly infectious and can cause severe pneumonia with respiratory distress (COVID-19). Scientists are doing research in order to prevent the viruses from multiplying.

Researchers worldwide have been looking for ways to treat COVID-19 since the pandemic began. Vaccines represent the best measure to prevent the disease, however, therapies remain in short supply. A ...

A new groundbreaking study from U-M reveals several drug contenders already in use for other purposes - including one dietary supplement - that have been shown to block or reduce SARS-CoV2 ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible omicron variant.

A new study evaluates the repRNA vaccine expressing the SARS-CoV-2 spike protein for the B.1.1.7 and B.1.351 variants in mice and hamsters.

The race to develop effective coronavirus treatments that can cure COVID-19 yielded more promising results. Regeneron announced that its monoclonal antibody compound was effective and … ...

A new groundbreaking study from U-M reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV2 ...

A groundbreaking study from U-M reveals several drug contenders already in use for other purposes—including one dietary supplement—that have been shown to block or reduce SARS-CoV2 infection ...